Supply Chain

Paris-based Sanofi will enter into a joint venture with the Swiss drug manufacturer Lonza to open a $285 million biologics facility by 2020, reports Reuters.

 While drugmakers typically raise list prices in January, many companies scaled back price hikes amid rising scrutiny over the cost of prescription drugs, reports The Wall Street Journal.

Nilesh Gupta, managing director of Lupin Pharmaceuticals, warned a potential border tax in the U.S. could be highly disruptive for Indian drug manufacturing companies, reports BloombergQuint.

Patients can often pay less for their generic medications if they sidestep insurance and pay out of pocket, but contracts with pharmacy benefit managers forbid pharmacists from telling customers this information, reports Chicago Tribune.

New Orleans-based LCMC Health will collaborate with The Resource Group, a subsidiary of St. Louis-based Ascension, to improve its resource and supply management operations.

A panel of healthcare industry leaders and experts met Wednesday in Washington, D.C., to discuss the state of the drug industry, along with strategies to improve payment and delivery systems in the market.

Here are the four latest drugs and medical devices approved by the Food and Drug Administration in the past week.

Toronto-based Intellipharmaceutics International earned Food and Drug Administration approval for its levetiracetam extended-release tablets.

The Food and Drug Administration granted market clearance to Seventh Sense Biosystems' new push-button blood collection device.

Here are six articles published by Becker's Hospital Review this past week featuring a look into Intermountain Healthcare's approach to supply chain management and a study on the urgency of medical device recalls, among other topics.